Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Maxygen, Inc.
Commercial Physical And Biological Research CA, United States
Nasdaq: MAXY
Company Description
Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.
Similar to: Medivir AB, Advanced Cell Technology, Inc., Exelixis, Inc.
Featured Company
Utilico Emerging Markets Ltd.
Epsom, SU, GB
Utilico Emerging Markets Ltd. (UEM) is the UK-based global emerging markets investment arm of Computershare, Ltd. (SY: CPU) in Australia.… Learn more →
Social Monitor
You may also be interested in:
Exelixis, Inc.
South San Francisco, CA, US
Exelixis, Inc. develops human therapeutics by innovating therapies for cancer and other serious diseases to various pharmaceutical… Learn more →
Advanced Cell Technology,…
Marlborough, MA, US
Advanced Cell Technology, Inc. is a biotechnology company that develops cellular therapies for the treatment of rare and common diseases… Learn more →
Medivir AB
Stockholm, SE
Medivir is a research based pharmaceutical company focused on infectious diseases and Nordic market presences were we market 15 products… Learn more →